<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>week-05-hw-protein-design-part-ii :: 2026a-kaleab-berhanu-weldesenbet</title><link>https://pages.htgaa.org/2026a/kaleab-berhanu-weldesenbet/homework/week-05-hw-protein-design-part-ii/index.html</link><description>Protein Design Part 2 SOD1_A4V Mutated Code Used. —&gt; MATKVVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTS AGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVV HEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ
Part 1: PepMLM Generated Peptides Summary The four PepMLM-generated peptides were conditioned on the SOD1 A4V mutant sequence with a target length of 12 amino acids, with the exception of Peptide 2, which came out at 15 residues. Perplexity scores reflect the model’s confidence in each binder, where a lower score indicates higher confidence. Peptide 1 (WLYGAAGVRWGX) has the lowest perplexity at 13.06, making it the model’s most confident prediction, though it contains an X residue at the final position, which represents an unresolved or masked amino acid and should be noted as a potential issue before advancing it further. Peptides 2, 3, and 4 all cluster between 17 and 20, reflecting moderate confidence. The known binder FLYRWLPSRRGG is included as a structural and therapeutic benchmark and does not carry a perplexity score since it was not generated by PepMLM.</description><generator>Hugo</generator><language>en</language><atom:link href="https://pages.htgaa.org/2026a/kaleab-berhanu-weldesenbet/homework/week-05-hw-protein-design-part-ii/index.xml" rel="self" type="application/rss+xml"/></channel></rss>